Cambria Biosciences Announces Discovery Collaboration With Syngenta (SYT)
10/19/2005 5:09:00 PM
Cambria Biosciences LLC, a drug discovery company, today announced a three-year collaboration with Syngenta Limited, a world leading agribusiness. Cambria will use its technology to elucidate the mechanism of action of small molecule compounds supplied by Syngenta to guide the discovery and development of new classes of safe and effective insecticides. Under the terms of the agreement, Syngenta will provide full research funding and certain in-kind resources to Cambria for this program. Financial terms were not disclosed.
comments powered by